千红制药：11月24日召开董事会会议

Group 1 - The core point of the article is that Qianhong Pharmaceutical announced the convening of its sixth board meeting to discuss the agenda for the second extraordinary shareholders' meeting in 2025 [1] - For the first half of 2025, Qianhong Pharmaceutical's revenue composition shows that the biopharmaceutical industry accounts for 99.67%, while other sectors account for 0.33% [1] - As of the report, Qianhong Pharmaceutical has a market capitalization of 10.7 billion yuan [1] Group 2 - The article also mentions that Dapeng Industrial's strategic placement has significantly benefited its insiders, with a subscription price of 9 yuan and a first-day listing price of 118 yuan, resulting in a floating profit of 24.92 million yuan for the controlling shareholder and his brother [1]